Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.62% | 53.18% | 40.99% | 19.78% | -13.55% |
| Total Depreciation and Amortization | -60.27% | -70.82% | -62.81% | -61.98% | -5.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.12% | -66.96% | -32.88% | -19.00% | 60.15% |
| Change in Net Operating Assets | 37.94% | 124.08% | 98.66% | 93.75% | 30.67% |
| Cash from Operations | 42.30% | 71.31% | 55.30% | 31.09% | 7.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 100.00% | -- | 4,525.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.25% | -97.76% | -70.95% | -83.54% | -358.03% |
| Cash from Investing | 116.27% | -97.73% | -70.36% | -82.72% | -351.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.08% | -319.16% | -98.98% | -120.66% | -119.16% |